AHR and lip and oral cavity carcinoma: AhR antagonists have been proven to be antioncogenic roles in several cancers, including lung, head and neck, and oral cancers etc. (DiNatale et al., 2011; DiNatale et al., 2012; Kolluri et al., 2017).